Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO Schwartz stock sales may be the key that unravels this conundrum
Reply New Message
Prev Message Back To Forum Threaded View Next Message

LOLOL



You're answering quesitons like Ken at Hawk! lol. You said a lot, but never answered anything I asked.



You can find my numbers here:



http://www.agoracom.com/ir/patriot/m...



Based on that and no Feb licenses, it leaves approx $22M for the J's. My simple yes or no question to you was: if that's the total value they'll get from the J's, do you consider it a win or a loss?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply